心臓構造デバイス市場：製品タイプ、手技タイプ、材料タイプ、用途、エンドユーザー別-2025-2030年の世界予測

心臓構造デバイス市場は、2024年に210億6,000万米ドルと評価され、2025年には230億1,000万米ドル、CAGR 9.60%で成長し、2030年には365億1,000万米ドルに達すると予測されています。

心臓構造機器のイノベーションは心臓治療の展望を再構築し、弁障害、欠損閉鎖、複雑な解剖学的課題を抱える患者に新たな希望をもたらしています。人口動態の変化により低侵襲治療への需要が高まる中、医療技術開発者は手技の安全性と患者の転帰を高める送達システムと材料を改良し続けています。これと並行して、規制機関も画期的なソリューションの承認を促進する経路を進化させており、イノベーションと政策の間の重要な相互作用が浮き彫りになっています。

近年、経カテーテル技術の進歩と機械弁および組織弁の設計の改良により、耐久性と血行力学的性能が大幅に改善されました。このような技術的な飛躍的進歩は、画像診断装置やガイドワイヤシステムの強化によって補完され、これらによって、より正確なデバイスの設置や回復時間の短縮が可能となりました。その結果、病院や心臓専門センターでは、一連の治療を最適化するために、これらのツールを活用した統合的な手技プロトコルの採用が増加しています。

経済的な圧力と償還モデルの変化は、質を落とすことなく費用対効果を高めることの重要性を強調しています。その結果、メーカー各社は先端ポリマーから生体適合性合金に至る新素材を探求する一方、次世代イントロデューサーシースやオクルーダー構成への投資も行っています。これらの開発は、この分野を前進させる多面的な推進力を浮き彫りにしています。

このエグゼクティブサマリーでは、変革的な市場シフト、関税への影響、セグメンテーションの洞察、地域別のダイナミクス、戦略的提言を総合的に検討し、意思決定者に情報を提供するとともに、心臓構造機器の革新への今後の投資の指針とします。

エコシステム全体の技術進歩、患者中心の医療動向、規制のマイルストーンに牽引される構造的心臓治療における変革的パラダイムシフトの特定

構造的心臓治療機器セクターは、技術的ブレークスルー、患者中心のケアモデル、進化する規制の枠組みの合流によって、変革的パラダイムシフトが進行しています。人工知能と機械学習が機器開発と交差し始めるにつれ、予測分析がより正確な患者選択と個別化された治療プロトコルを可能にしています。データ主導の意思決定へのこのシフトは、患者固有のインプラント設計と迅速なプロトタイピングを促進する3Dプリンティング技術の拡大によって補完されています。

米国の関税が心臓構造装置のサプライチェーン、コスト構造、経営回復力、戦略的製造上の決断に及ぼす遠大な影響の評価

2025年に発効する米国の関税政策は、心臓構造機器のサプライチェーンに重大な影響を及ぼし、業界全体の戦略的再調整を促す構えです。輸入部品に大きく依存しているメーカーは、特に海外のサプライヤーから調達する特殊な金属合金やポリマー材料の投入コストの上昇に直面しています。このような調達コストの高騰は、コスト増を吸収するか、あるいは負担を下流に転嫁する必要があり、価格設定や償還交渉に支障をきたす可能性があります。

製品、手順、材料、用途、エンドユーザーに関する洞察を明らかにする重要なセグメンテーションの次元を解読することで、構造心臓デバイスの戦略と成果を促進する

重要なセグメンテーションの洞察は、製品、手技、材料、用途、エンドユーザーの各次元における微妙なビジネスチャンスを明らかにし、それぞれが目標とする戦略的イニシアチブに情報を提供します。製品タイプ別では、デリバリーシステム、ガイドワイヤー、イントロデューサーシースなどのアクセサリーデバイスがモジュール型イノベーションの価値を示し、機械式、組織式、トランスカテーテル型などの心臓弁デバイスが侵襲性の低いインプラントへの嗜好の進化を浮き彫りにしています。心房中隔欠損閉塞器や左心房付属器閉塞ソリューションを含む閉塞器と閉鎖器は、経皮的インターベンションの範囲の拡大をさらに強調しています。

南北アメリカ、中東アフリカ、アジア太平洋市場の構造的心臓デバイスの採用パターンを形成する地域力学と成長促進要因の解明

構造的心臓装置の分野における地域ダイナミクスの特徴は、南北アメリカ、欧州中東アフリカ、アジア太平洋地域における明確な成長促進要因と採用パターンです。南北アメリカでは、高度なヘルスケア・インフラと確立された償還モデルが、次世代トランスカテーテル治療の迅速な統合を支えています。主要な病院や専門センターは、集学的チームや高忠実度の画像処理設備に多額の投資を行い、手技の革新や臨床試験を促進する環境を醸成しています。一方、外来手術センターでは、低侵襲プログラムへの参加が増えており、治療へのアクセスを拡大し、全体的な治療費を削減しています。

主要メーカーの戦略的動きと競合情勢を解明革新とパートナーシップで心臓構造治療機器の情勢を再構築

大手メーカーは、技術革新、戦略的提携、標的を絞った買収を通じて、競争上の差別化を維持するための大胆な取り組みを行っています。バルブ技術で伝統的な強みを持つ企業は、数十年にわたる臨床データを活用してデバイスの機能強化をサポートしながら、次世代トランスカテーテル・ソリューションへの投資を続けています。同時に、新興企業も破壊的な素材と独自の展開メカニズムで市場に参入し、研究機関とパートナーシップを結んで前臨床検証を加速させています。

市場での地位を最大化するための戦略的ロードマップ：構造用心臓デバイスの成長促進、協力関係の強化、イノベーション推進のための実行可能な提言

進化する構造的心臓デバイス環境を乗り切るために、業界リーダーはデジタルヘルスソリューションの統合を優先し、遠隔モニタリングプラットフォームと予測分析を可能にして、患者の選択と処置後の管理に情報を提供すべきです。このような投資は、臨床転帰の改善を促進し、継続的なデータ・フィードバック・ループを通じて長期的な機器性能を強化します。さらに、二重調達戦略や地域製造ハブの確立によるサプライチェーンの多様化は、関税の変動や物流の混乱に直面した際の事業回復力を強化します。

データ収集から検証、統合、専門家レビューに至るまで、包括的な構造心臓デバイス分析を支える厳密な調査手法の解明

この構造的心臓デバイス分析を支える調査手法は、包括的な調査対象範囲とデータの完全性を確保するために、厳格な1次調査と2次調査のフェーズを組み合わせたものです。1次調査では、心臓専門医、インターベンション専門医、多様なヘルスケア環境における調達担当幹部への詳細なインタビューに加え、技術動向、関税の影響、地域ダイナミクスに関するセンチメントを把握するため、業界利害関係者への調査を実施しました。

利害関係者および意思決定者にとっての心臓構造機器の動向、戦略的課題、革新的な促進要因、今後の方向性を示す主なハイライトのまとめ

本エグゼクティブサマリーでは、変革的な技術シフトから今後の関税政策の微妙な意味合いまで、構造用心臓デバイス分野を形成する重要な動向を明らかにしました。セグメンテーションの洞察により、手順の嗜好、材料の革新、多様なエンドユーザー要件に合わせた製品開発の重要性が浮き彫りになりました。地域別分析では、既存市場と新興市場それぞれで異なる採用力学が明らかになり、ビジネスチャンスがあることが浮き彫りになりました。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場力学

• 構造的心臓デバイスの設計と提供における患者固有のカスタマイズへの注目の高まり
• 心血管疾患の罹患率の上昇により、革新的な心臓デバイスの需要が増加
• 心臓構造デバイスにリンクした遠隔患者モニタリングシステムの拡張
• より安全な構造的心臓インプラントのための生分解性材料への投資の増加
• 患者の転帰を改善する低侵襲性構造的心臓デバイス技術の進歩
• デバイスのイノベーションを加速するテクノロジー企業と医療技術企業の連携
• 規制枠組みの変化が進み、新しい心臓デバイスの承認が加速している
• 心臓構造デバイスの正確な配置を支援するリアルタイム画像技術の開発
• 先天性心疾患の治療における構造的心臓デバイスの適用拡大
• 経カテーテル弁治療の成長が市場の大幅な拡大を促進

第6章 市場洞察

• ポーターのファイブフォース分析
• PESTEL分析

第7章 米国の関税の累積的な影響2025

第8章 心臓構造デバイス市場：製品タイプ別

• アクセサリデバイス
  • 配送システム
  • ガイドワイヤー
  • イントロデューサーシース
• 環状形成リング
• 心臓弁デバイス
  • 人工心臓弁
  • 組織心臓弁
  • 経カテーテル心臓弁
• 閉塞器具および閉鎖デバイス
  • 心房中隔欠損閉鎖器
  • 左心耳閉鎖デバイス
  • 開存卵円孔閉鎖器
  • 心室中隔欠損閉鎖器

第9章 心臓構造デバイス市場処置の種類別

• 低侵襲手術
• 開胸手術

第10章 心臓構造デバイス市場：素材タイプ別

• 金属合金
• ポリマー材料
• 組織材料

第11章 心臓構造デバイス市場：用途別

• 外科的大動脈弁置換術
• 経カテーテル大動脈弁置換術
• 経カテーテル僧帽弁修復術

第12章 心臓構造デバイス市場：エンドユーザー別

• 外来手術センター
• 病院
• 専門心臓センター

第13章 南北アメリカの心臓構造デバイス市場

• 米国
• カナダ
• メキシコ
• ブラジル
• アルゼンチン

第14章 欧州・中東・アフリカの心臓構造デバイス市場

• 英国
• ドイツ
• フランス
• ロシア
• イタリア
• スペイン
• アラブ首長国連邦
• サウジアラビア
• 南アフリカ
• デンマーク
• オランダ
• カタール
• フィンランド
• スウェーデン
• ナイジェリア
• エジプト
• トルコ
• イスラエル
• ノルウェー
• ポーランド
• スイス

第15章 アジア太平洋地域の心臓構造デバイス市場

• 中国
• インド
• 日本
• オーストラリア
• 韓国
• インドネシア
• タイ
• フィリピン
• マレーシア
• シンガポール
• ベトナム
• 台湾

第16章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合分析
  • Abbott Laboratories
  • AMETEK.Inc.
  • Artivion, Inc.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Braile Biomedica Industria, Comercio e Representacoes Ltda.
  • B. Braun Medical Inc.
  • Cardinal Health, Inc.
  • Direct Flow Medical, Inc.
  • Edwards Lifesciences Corporation
  • JenaValve Technology, Inc.
  • Johnson & Johnson Services, Inc.
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • Livanova PLC
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • Micro Interventional Devices, Inc.
  • MicroPort Scientific Corporation's
  • Relisys Medical Devices Limited.
  • TE Connectivity Corporation
  • Teleflex Incorporated.
  • Terumo Corporation
  • TTK Healthcare Limited

第17章 リサーチAI

第18章 リサーチ統計

第19章 リサーチコンタクト

第20章 リサーチ記事

第21章 付録

LIST OF FIGURES

• FIGURE 1. STRUCTURAL HEART DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 3. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 4. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
• FIGURE 6. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
• FIGURE 8. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
• FIGURE 10. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 12. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
• FIGURE 14. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 15. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 16. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 17. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 18. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 21. ASIA-PACIFIC STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 22. ASIA-PACIFIC STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 23. STRUCTURAL HEART DEVICES MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 24. STRUCTURAL HEART DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
• FIGURE 25. STRUCTURAL HEART DEVICES MARKET: RESEARCHAI
• FIGURE 26. STRUCTURAL HEART DEVICES MARKET: RESEARCHSTATISTICS
• FIGURE 27. STRUCTURAL HEART DEVICES MARKET: RESEARCHCONTACTS
• FIGURE 28. STRUCTURAL HEART DEVICES MARKET: RESEARCHARTICLES

LIST OF TABLES

• TABLE 1. STRUCTURAL HEART DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, 2025-2030 (USD MILLION)
• TABLE 5. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
• TABLE 7. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
• TABLE 9. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 11. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 13. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY DELIVERY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY DELIVERY SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 15. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 17. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY INTRODUCER SHEATHS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY INTRODUCER SHEATHS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 19. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
• TABLE 21. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 23. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 25. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 27. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY TISSUE HEART VALVES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY TISSUE HEART VALVES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 29. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 31. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2025-2030 (USD MILLION)
• TABLE 33. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 35. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY ATRIAL SEPTAL DEFECT OCCLUDERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY ATRIAL SEPTAL DEFECT OCCLUDERS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 37. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY LEFT ATRIAL APPENDAGE CLOSURE DEVICES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY LEFT ATRIAL APPENDAGE CLOSURE DEVICES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 39. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY PATENT FORAMEN OVALE OCCLUDERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY PATENT FORAMEN OVALE OCCLUDERS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 41. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY VENTRICULAR SEPTAL DEFECT OCCLUDERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY VENTRICULAR SEPTAL DEFECT OCCLUDERS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 43. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2025-2030 (USD MILLION)
• TABLE 45. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 47. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2025-2030 (USD MILLION)
• TABLE 49. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY OPEN-HEART SURGERY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY OPEN-HEART SURGERY, BY REGION, 2025-2030 (USD MILLION)
• TABLE 51. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
• TABLE 53. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY METALLIC ALLOYS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY METALLIC ALLOYS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 55. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY POLYMER MATERIALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY POLYMER MATERIALS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 57. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY TISSUE MATERIALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY TISSUE MATERIALS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 59. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 61. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY SURGICAL AORTIC VALVE REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY SURGICAL AORTIC VALVE REPLACEMENT, BY REGION, 2025-2030 (USD MILLION)
• TABLE 63. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY TRANSCATHETER AORTIC VALVE REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY TRANSCATHETER AORTIC VALVE REPLACEMENT, BY REGION, 2025-2030 (USD MILLION)
• TABLE 65. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY TRANSCATHETER MITRAL VALVE REPAIR, BY REGION, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY TRANSCATHETER MITRAL VALVE REPAIR, BY REGION, 2025-2030 (USD MILLION)
• TABLE 67. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 69. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 71. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 73. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY SPECIALTY CARDIAC CENTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY SPECIALTY CARDIAC CENTERS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 75. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 76. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 77. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
• TABLE 78. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
• TABLE 79. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2024 (USD MILLION)
• TABLE 80. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2025-2030 (USD MILLION)
• TABLE 81. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2024 (USD MILLION)
• TABLE 82. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2025-2030 (USD MILLION)
• TABLE 83. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 84. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 85. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
• TABLE 86. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
• TABLE 87. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 88. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 89. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 90. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 91. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 92. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
• TABLE 93. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 94. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 95. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
• TABLE 96. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
• TABLE 97. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2024 (USD MILLION)
• TABLE 98. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2025-2030 (USD MILLION)
• TABLE 99. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2024 (USD MILLION)
• TABLE 100. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2025-2030 (USD MILLION)
• TABLE 101. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 102. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 103. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
• TABLE 104. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
• TABLE 105. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 106. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 107. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 108. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 109. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
• TABLE 110. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
• TABLE 111. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 112. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 113. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
• TABLE 114. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
• TABLE 115. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2024 (USD MILLION)
• TABLE 116. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2025-2030 (USD MILLION)
• TABLE 117. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2024 (USD MILLION)
• TABLE 118. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2025-2030 (USD MILLION)
• TABLE 119. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 120. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 121. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
• TABLE 122. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
• TABLE 123. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 124. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 125. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 126. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 127. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 128. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 129. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
• TABLE 130. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
• TABLE 131. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2024 (USD MILLION)
• TABLE 132. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2025-2030 (USD MILLION)
• TABLE 133. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2024 (USD MILLION)
• TABLE 134. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2025-2030 (USD MILLION)
• TABLE 135. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 136. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 137. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
• TABLE 138. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
• TABLE 139. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 140. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 141. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 142. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 143. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 144. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 145. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
• TABLE 146. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
• TABLE 147. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2024 (USD MILLION)
• TABLE 148. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2025-2030 (USD MILLION)
• TABLE 149. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2024 (USD MILLION)
• TABLE 150. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2025-2030 (USD MILLION)
• TABLE 151. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 152. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 153. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
• TABLE 154. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
• TABLE 155. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 156. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 157. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 158. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 159. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 160. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 161. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
• TABLE 162. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
• TABLE 163. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2024 (USD MILLION)
• TABLE 164. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2025-2030 (USD MILLION)
• TABLE 165. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2024 (USD MILLION)
• TABLE 166. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2025-2030 (USD MILLION)
• TABLE 167. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 168. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 169. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
• TABLE 170. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
• TABLE 171. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 172. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 173. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 174. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 175. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 176. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 177. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
• TABLE 178. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
• TABLE 179. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2024 (USD MILLION)
• TABLE 180. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2025-2030 (USD MILLION)
• TABLE 181. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2024 (USD MILLION)
• TABLE 182. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2025-2030 (USD MILLION)
• TABLE 183. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 184. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 185. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
• TABLE 186. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
• TABLE 187. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 188. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 189. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 190. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 191. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 192. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
• TABLE 193. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 194. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 195. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
• TABLE 196. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
• TABLE 197. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2024 (USD MILLION)
• TABLE 198. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2025-2030 (USD MILLION)
• TABLE 199. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2024 (USD MILLION)
• TABLE 200. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2025-2030 (USD MILLION)
• TABLE 201. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 202. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 203. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
• TABLE 204. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
• TABLE 205. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 206. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 207. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 208. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 209. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 210. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 211. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
• TABLE 212. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
• TABLE 213. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2024 (USD MILLION)
• TABLE 214. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2025-2030 (USD MILLION)
• TABLE 215. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2024 (USD MILLION)
• TABLE 216. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2025-2030 (USD MILLION)
• TABLE 217. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 218. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 219. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
• TABLE 220. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
• TABLE 221. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 222. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 223. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 224. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 225. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 226. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 227. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
• TABLE 228. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
• TABLE 229. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2024 (USD MILLION)
• TABLE 230. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2025-2030 (USD MILLION)
• TABLE 231. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2024 (USD MILLION)
• TABLE 232. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2025-2030 (USD MILLION)
• TABLE 233. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 234. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 235. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
• TABLE 236. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
• TABLE 237. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 238. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 239. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 240. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 241. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 242. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 243. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
• TABLE 244. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
• TABLE 245. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2024 (USD MILLION)
• TABLE 246. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2025-2030 (USD MILLION)
• TABLE 247. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2024 (USD MILLION)
• TABLE 248. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2025-2030 (USD MILLION)
• TABLE 249. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 250. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 251. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
• TABLE 252. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
• TABLE 253. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 254. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 255. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 256. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 257. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 258. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 259. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
• TABLE 260. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
• TABLE 261. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2024 (USD MILLION)
• TABLE 262. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2025-2030 (USD MILLION)
• TABLE 263. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2024 (USD MILLION)
• TABLE 264. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2025-2030 (USD MILLION)
• TABLE 265. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 266. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 267. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
• TABLE 268. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
• TABLE 269. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 270. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 271. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 272. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 273. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 274. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 275. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
• TABLE 276. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
• TABLE 277. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2024 (USD MILLION)
• TABLE 278. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2025-2030 (USD MILLION)
• TABLE 279. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2024 (USD MILLION)
• TABLE 280. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2025-2030 (USD MILLION)
• TABLE 281. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 282. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 283. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
• TABLE 284. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
• TABLE 285. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 286. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 287. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 288. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 289. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 290. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 291. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
• TABLE 292. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
• TABLE 293. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2024 (USD MILLION)
• TABLE 294. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2025-2030 (USD MILLION)
• TABLE 295. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2024 (USD MILLION)
• TABLE 296. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2025-2030 (USD MILLION)
• TABLE 297. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
• TABLE 298. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
• TABLE 299. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
• TABLE 300. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
• TABLE 301. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 302. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 303. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 304. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 305. SAUDI ARABIA STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 306. SAUDI ARABIA STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 307. SAUDI ARABIA STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
• TABLE 308. SAUDI ARABIA STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
• TABLE 309. SAUDI ARABIA STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2024 (USD MILLION)
• TABLE 310. SAUDI ARABIA STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2025-2030 (USD MILLION)
• TABLE 311. SAUDI ARABIA STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 201

The Structural Heart Devices Market was valued at USD 21.06 billion in 2024 and is projected to grow to USD 23.01 billion in 2025, with a CAGR of 9.60%, reaching USD 36.51 billion by 2030.

Structural heart device innovations are reshaping the landscape of cardiac care, offering new hope to patients with valve disorders, defect closures, and complex anatomical challenges. As demographic shifts drive greater demand for minimally invasive interventions, medical technology developers continue to refine delivery systems and materials that enhance procedural safety and patient outcomes. In parallel, regulatory bodies are evolving pathways to facilitate accelerated approvals for breakthrough solutions, underscoring the critical interplay between innovation and policy.

In recent years, advances in transcatheter techniques and the refinement of mechanical and tissue valve designs have led to substantial improvements in durability and hemodynamic performance. These technological breakthroughs have been complemented by enhanced imaging modalities and guidewire systems, which collectively support more precise device placement and reduced recovery times. As a result, hospitals and specialty cardiac centers are increasingly adopting integrated procedural protocols that leverage these tools to optimize the continuum of care.

Economic pressures and shifting reimbursement models have emphasized the importance of cost-effectiveness without compromising quality. Consequently, manufacturers are exploring novel materials ranging from advanced polymers to biocompatible alloys, while also investing in next-generation introducer sheaths and occluder configurations. These developments highlight the multifaceted drivers that are propelling the field forward.

This executive summary provides a cohesive exploration of transformative market shifts, tariff implications, segmentation insights, regional dynamics, and strategic recommendations to inform decision makers and guide future investments in structural heart device innovations.

Identifying Transformative Paradigm Shifts in Structural Heart Therapy Driven by Technological Advances, Patient-Centric Care Trends, and Regulatory Milestones Across the Ecosystem

The structural heart device sector is undergoing transformative paradigm shifts, driven by a confluence of technological breakthroughs, patient-centric care models, and evolving regulatory frameworks. As artificial intelligence and machine learning begin to intersect with device development, predictive analytics are enabling more accurate patient selection and personalized therapy protocols. This shift toward data-driven decision making is complemented by the expansion of 3D printing technologies that facilitate patient-specific implant design and rapid prototyping.

Meanwhile, there has been a pronounced movement toward minimally invasive procedures, reflecting growing patient preference for reduced hospitalization and expedited recovery. This trend has prompted developers to optimize delivery systems and guidewire flexibility, thereby enhancing procedural precision. Concurrently, remote monitoring platforms are maturing, allowing clinicians to track post-procedure hemodynamics and detect device-related complications at an early stage. Such capabilities promote proactive clinical management and foster continuous device improvement.

Regulatory milestones are also redefining market entry pathways. Accelerated approval programs, conditional on real-world evidence collection, are expediting access to groundbreaking therapies while maintaining rigorous safety standards. As a result, stakeholders across the ecosystem are recalibrating their strategies to align with both expedited approvals and long-term post-market surveillance commitments. Together, these transformative shifts underscore an era of rapid innovation, heightened collaboration, and patient-centered excellence within the structural heart device landscape.

Assessing the Far-Reaching Implications of United States Tariffs on Structural Heart Device Supply Chains, Cost Structures, Operational Resilience, and Strategic Manufacturing Decisions

United States tariff policies set to take effect in 2025 are poised to exert significant influence on structural heart device supply chains, thereby prompting strategic recalibrations across the industry. Manufacturers heavily reliant on imported components face rising input costs, particularly for specialized metallic alloys and polymer materials sourced from international suppliers. This escalation in procurement expenses necessitates either absorption of incremental costs or transfer of burdens downstream, which could challenge pricing structures and reimbursement negotiations.

In response, many organizations are exploring nearshoring initiatives to establish or expand domestic manufacturing capabilities. Such operational shifts enhance supply chain resilience, mitigate currency fluctuations, and reduce logistical complexities. Yet, these transitions demand substantial capital investment in facility expansion and workforce training. At the same time, partnerships with local contract manufacturers are gaining prominence, offering a more flexible approach to capacity scaling without requiring full vertical integration.

Moreover, tariff-induced cost pressures are catalyzing a renewed emphasis on material innovation. Research into alternative biocompatible substrates and hybrid composites is intensifying, with the goal of preserving performance while lowering dependence on tariff-affected imports. Stakeholders are also consolidating purchasing agreements and leveraging consortium models to negotiate more favorable terms with suppliers. These strategic responses collectively reflect an industry adapting to shifting trade landscapes and striving to protect both profitability and patient access.

Ultimately, the cumulative impact of these tariffs is not uniform but varies by device category and regional operational footprint. Forward-looking companies are engaging in scenario planning to anticipate potential policy adjustments, ensuring that their manufacturing and distribution networks remain robust in the face of evolving trade conditions.

Decoding Critical Segmentation Dimensions Revealing Product, Procedural, Material, Application, and End User Insights Propelling Structural Heart Device Strategies and Outcomes

Critical segmentation insights reveal nuanced opportunities across product, procedure, material, application, and end user dimensions, each informing targeted strategic initiatives. When examining product types, accessory devices such as delivery systems, guidewires, and introducer sheaths demonstrate the value of modular innovation, while heart valve devices encompassing mechanical, tissue, and transcatheter variants highlight evolving preferences toward less invasive implants. Occluders and closure devices, which include atrial septal defect occluders and left atrial appendage closure solutions, further underscore the expanding scope of percutaneous interventions.

Across procedural approaches, the dichotomy between minimally invasive surgery and open-heart surgery speaks to diverging clinical pathways. Minimally invasive techniques continue to gain traction due to shorter hospital stays and lower complication rates, yet open-heart procedures remain integral for complex cases requiring direct visualization. This procedural segmentation ties back to material considerations, where choices among metallic alloys, polymer materials, or tissue-based substrates influence device performance, biocompatibility, and long-term durability.

Application-based segmentation provides additional granularity, as therapies range from surgical aortic valve replacement to transcatheter aortic valve replacement and transcatheter mitral valve repair. Each application's unique anatomical and hemodynamic requirements drive distinct design parameters, procedural protocols, and post-implantation care regimens. Finally, segmentation by end user-including ambulatory surgical centers, hospitals, and specialty cardiac centers-illuminates varying adoption patterns, procurement cycles, and training needs. Together, these segmentation dimensions offer a comprehensive framework for aligning product development, marketing strategies, and clinical engagement initiatives with the dynamic demands of the structural heart device market.

Illuminating Regional Dynamics and Growth Drivers Shaping Structural Heart Device Adoption Patterns across the Americas, Europe Middle East Africa, and Asia-Pacific Markets

Regional dynamics within the structural heart device arena are characterized by distinct growth drivers and adoption patterns across the Americas, Europe Middle East Africa, and Asia-Pacific. In the Americas, advanced healthcare infrastructure and established reimbursement models support swift integration of next-generation transcatheter therapies. Leading hospitals and specialty centers invest heavily in multidisciplinary teams and high-fidelity imaging suites, thereby fostering an environment conducive to procedural innovation and clinical trials. Meanwhile, ambulatory surgical centers are increasingly participating in minimally invasive programs, expanding access to care and reducing overall treatment costs.

In Europe Middle East Africa, heterogeneous regulatory landscapes and variable healthcare funding models influence market penetration rates. Western European nations display robust uptake of percutaneous valves and occlusion devices, driven by concerted policy support and centralized purchasing agreements. At the same time, emerging markets in the Middle East and Africa are experiencing incremental growth, propelled by expanding cardiovascular disease awareness and incremental investments in interventional cardiology training.

The Asia-Pacific region represents a rapidly evolving frontier, fueled by an aging population, rising disposable incomes, and broadening hospital capacities. Countries such as Japan and Australia maintain sophisticated procedural ecosystems, while China and India are accelerating domestic manufacturing capabilities and forging strategic international partnerships. Collectively, these regional insights underscore the importance of tailoring market entry strategies, regulatory navigation plans, and distribution networks to the unique healthcare landscapes that define each geographic cluster.

Uncovering Strategic Movements and Competitive Differentiators among Leading Manufacturers Reshaping the Structural Heart Device Landscape through Innovation and Partnerships

Leading manufacturers are undertaking bold initiatives to maintain competitive differentiation through innovation, strategic collaborations, and targeted acquisitions. Corporations with legacy strength in valve technologies continue to invest in next-generation transcatheter solutions, leveraging decades of clinical data to support device enhancements. Simultaneously, emerging players are entering the market with disruptive materials and proprietary deployment mechanisms, forging partnerships with research institutions to accelerate preclinical validations.

Cross-industry alliances are becoming more prevalent, as technology firms contribute advanced analytics platforms and digital monitoring solutions to established device portfolios. Such collaborations enable remote patient surveillance and real-time procedural guidance, creating holistic ecosystems that extend beyond the cath lab. At the same time, established conglomerates are streamlining operational footprints by divesting non-core assets, redirecting capital toward structural heart programs with the highest strategic impact.

Mergers and acquisitions remain a pivotal strategy for scaling market reach and expanding therapeutic pipelines. By integrating complementary technologies-from polymer innovations to artificial intelligence-driven imaging-companies can offer turnkey solutions that address multiple points along the patient care continuum. This trend underscores the value of a diversified portfolio that blends mechanical, tissue, and transcatheter valve offerings with advanced occluder and closure devices.

Collectively, these competitive maneuvers illustrate an industry in flux, where success hinges on the ability to converge clinical excellence, digital integration, and agile operational models. Stakeholders that manage to balance these elements effectively will be best positioned to shape the next chapter of structural heart interventions.

Strategic Roadmap for Maximizing Market Position: Actionable Recommendations to Propel Growth, Enhance Collaboration, and Drive Innovation in Structural Heart Devices

To navigate the evolving structural heart device environment, industry leaders should prioritize the integration of digital health solutions, enabling remote monitoring platforms and predictive analytics to inform patient selection and post-procedure management. Such investments foster improved clinical outcomes and reinforce long-term device performance through continuous data feedback loops. Moreover, diversifying supply chains by establishing dual sourcing strategies and regional manufacturing hubs will bolster operational resilience in the face of tariff fluctuations and logistical disruptions.

Engagement with regulatory agencies remains critical; proactive collaboration on real-world evidence initiatives and conditional approval pathways can accelerate market access while ensuring robust safety monitoring. Concurrently, seeking strategic alliances and targeted acquisitions will enhance technology portfolios, allowing manufacturers to offer comprehensive procedural suites that span from delivery system innovation to advanced occlusion therapies. By embracing these collaborative models, organizations can achieve economies of scale and reduce time to market.

Finally, centering strategic planning around patient outcomes-through investment in biocompatible materials, minimally invasive delivery platforms, and clinician training programs-will drive differentiation and support favorable reimbursement conversations. Leaders that align business objectives with demonstrable clinical value and operational agility will be poised to capture emerging opportunities and sustain competitive advantage in the structural heart device landscape.

Elucidating Rigorous Research Methodology Underpinning the Comprehensive Structural Heart Device Analysis from Data Collection through Validation, Synthesis, and Expert Review

The research methodology underpinning this structural heart device analysis combines rigorous primary and secondary research phases to ensure comprehensive coverage and data integrity. Primary research involved detailed interviews with cardiologists, interventional specialists, and procurement executives across diverse healthcare settings, complemented by surveys of industry stakeholders to capture sentiment on technological trends, tariff impacts, and regional dynamics.

Secondary research encompassed an exhaustive review of peer-reviewed journals, regulatory filings, clinical trial registries, and company disclosures, providing a robust foundation of historical and contemporary insights. This process was further supported by extraction of device-specific information from patent databases and assessment of regulatory approvals to contextualize market entry timelines and post-market surveillance obligations.

Data validation was conducted through triangulation of multiple sources, including cross-referencing interview feedback with published literature and manufacturer reports. Analytical frameworks were applied to synthesize segmentation dimensions, tariff scenarios, and competitive strategies, ensuring logical coherence and actionable relevance. An expert panel comprising clinical advisors and industry analysts then reviewed draft findings, providing critical input to refine interpretations and validate strategic recommendations.

This multilayered approach guarantees that the insights presented are both empirically grounded and reflective of evolving market realities, equipping decision makers with the clarity needed to navigate the structural heart device space with confidence.

Synthesis of Key Takeaways Highlighting Structural Heart Device Trends, Strategic Imperatives, Innovative Drivers, and Future Directions for Stakeholders and Decision Makers

This executive summary has illuminated the critical trends shaping the structural heart device sector, from transformative technological shifts to the nuanced implications of upcoming tariff policies. Segmentation insights have underscored the importance of aligning product development with procedural preferences, material innovations, and varied end user requirements. Regional analyses have revealed distinct adoption dynamics, highlighting opportunities in established and emerging markets alike.

Key company strategies have demonstrated how innovation ecosystems are coalescing around digital integration, advanced materials research, and strategic partnerships. Actionable recommendations emphasize the need for diversified supply chains, proactive regulatory engagement, and a relentless focus on patient outcomes. By synthesizing these insights, industry leaders can better anticipate market demands, optimize operational resilience, and accelerate the delivery of life-saving therapies.

Looking forward, the structural heart device landscape will continue to evolve in response to demographic pressures, policy shifts, and technological breakthroughs. Stakeholders equipped with timely, evidence-based intelligence will be uniquely positioned to drive sustainable growth, foster clinical excellence, and ultimately improve the lives of patients with complex cardiac conditions. This summary serves as a roadmap for navigating the complexities of a dynamic market and seizing the strategic opportunities that lie ahead.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Market Sizing & Forecasting

5. Market Dynamics

• 5.1. Increasing focus on patient-specific customization in structural heart device design and delivery
• 5.2. Rising prevalence of cardiovascular diseases increasing demand for innovative heart devices
• 5.3. Expansion of remote patient monitoring systems linked to structural heart devices
• 5.4. Growing investments in biodegradable materials for safer structural heart implants
• 5.5. Advancements in minimally invasive structural heart device technologies enhancing patient outcomes
• 5.6. Collaborations among tech companies and medtech firms accelerating device innovation
• 5.7. Increasing shifts in regulatory frameworks influencing faster approvals of novel heart devices
• 5.8. Development of real-time imaging technologies aiding precise structural heart device placement
• 5.9. Expansion of structural heart device applications in treating congenital heart defects
• 5.10. Growth of transcatheter valve therapies fueling significant market expansion

6. Market Insights

• 6.1. Porter's Five Forces Analysis
• 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Structural Heart Devices Market, by Product Type

• 8.1. Introduction
• 8.2. Accessory Devices
  • 8.2.1. Delivery Systems
  • 8.2.2. Guidewires
  • 8.2.3. Introducer Sheaths
• 8.3. Annuloplasty Rings
• 8.4. Heart Valve Devices
  • 8.4.1. Mechanical Heart Valves
  • 8.4.2. Tissue Heart Valves
  • 8.4.3. Transcatheter Heart Valves
• 8.5. Occluders & Closure Devices
  • 8.5.1. Atrial Septal Defect Occluders
  • 8.5.2. Left Atrial Appendage Closure Devices
  • 8.5.3. Patent Foramen Ovale Occluders
  • 8.5.4. Ventricular Septal Defect Occluders

9. Structural Heart Devices Market, by Procedure Type

• 9.1. Introduction
• 9.2. Minimally Invasive Surgery
• 9.3. Open-Heart Surgery

10. Structural Heart Devices Market, by Material Type

• 10.1. Introduction
• 10.2. Metallic Alloys
• 10.3. Polymer Materials
• 10.4. Tissue Materials

11. Structural Heart Devices Market, by Application

• 11.1. Introduction
• 11.2. Surgical Aortic Valve Replacement
• 11.3. Transcatheter Aortic Valve Replacement
• 11.4. Transcatheter Mitral Valve Repair

12. Structural Heart Devices Market, by End User

• 12.1. Introduction
• 12.2. Ambulatory Surgical Centers
• 12.3. Hospitals
• 12.4. Specialty Cardiac Centers

13. Americas Structural Heart Devices Market

• 13.1. Introduction
• 13.2. United States
• 13.3. Canada
• 13.4. Mexico
• 13.5. Brazil
• 13.6. Argentina

14. Europe, Middle East & Africa Structural Heart Devices Market

• 14.1. Introduction
• 14.2. United Kingdom
• 14.3. Germany
• 14.4. France
• 14.5. Russia
• 14.6. Italy
• 14.7. Spain
• 14.8. United Arab Emirates
• 14.9. Saudi Arabia
• 14.10. South Africa
• 14.11. Denmark
• 14.12. Netherlands
• 14.13. Qatar
• 14.14. Finland
• 14.15. Sweden
• 14.16. Nigeria
• 14.17. Egypt
• 14.18. Turkey
• 14.19. Israel
• 14.20. Norway
• 14.21. Poland
• 14.22. Switzerland

15. Asia-Pacific Structural Heart Devices Market

• 15.1. Introduction
• 15.2. China
• 15.3. India
• 15.4. Japan
• 15.5. Australia
• 15.6. South Korea
• 15.7. Indonesia
• 15.8. Thailand
• 15.9. Philippines
• 15.10. Malaysia
• 15.11. Singapore
• 15.12. Vietnam
• 15.13. Taiwan

16. Competitive Landscape

• 16.1. Market Share Analysis, 2024
• 16.2. FPNV Positioning Matrix, 2024
• 16.3. Competitive Analysis
  • 16.3.1. Abbott Laboratories
  • 16.3.2. AMETEK.Inc.
  • 16.3.3. Artivion, Inc.
  • 16.3.4. BIOTRONIK SE & Co. KG
  • 16.3.5. Boston Scientific Corporation
  • 16.3.6. Braile Biomedica Industria, Comercio e Representacoes Ltda.
  • 16.3.7. B. Braun Medical Inc.
  • 16.3.8. Cardinal Health, Inc.
  • 16.3.9. Direct Flow Medical, Inc.
  • 16.3.10. Edwards Lifesciences Corporation
  • 16.3.11. JenaValve Technology, Inc.
  • 16.3.12. Johnson & Johnson Services, Inc.
  • 16.3.13. Lepu Medical Technology (Beijing) Co., Ltd.
  • 16.3.14. Livanova PLC
  • 16.3.15. Medtronic plc
  • 16.3.16. Meril Life Sciences Pvt. Ltd.
  • 16.3.17. Micro Interventional Devices, Inc.
  • 16.3.18. MicroPort Scientific Corporation's
  • 16.3.19. Relisys Medical Devices Limited.
  • 16.3.20. TE Connectivity Corporation
  • 16.3.21. Teleflex Incorporated.
  • 16.3.22. Terumo Corporation
  • 16.3.23. TTK Healthcare Limited

17. ResearchAI

18. ResearchStatistics

19. ResearchContacts

20. ResearchArticles

21. Appendix